AUTHOR=Wu Xiaohui , Zhu Yuncheng , Wu Zhiguo , Huang Jia , Cao Lan , Wang Yun , Su Yousong , Liu Hongmei , Fang Maosheng , Yao Zhijian , Wang Zuowei , Wang Fan , Wang Yong , Peng Daihui , Chen Jun , Fang Yiru 

TITLE=Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis

JOURNAL=Frontiers in Psychiatry

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2022.759334

DOI=10.3389/fpsyt.2022.759334

ISSN=1664-0640

ABSTRACT=<sec><title>Background</title><p>Two-thirds of major depressive disorder (MDD) patients initially present with somatic symptoms, yet no study has used approaches based on somatic symptoms to subtype MDD. This study aimed to classify MDD <italic>via</italic> somatic symptoms and tracked the prognosis of each subtype.</p></sec><sec><title>Methods</title><p>Data were obtained from the study of Algorithm Guided Treatment Strategies for Major Depressive Disorder (AGTs-MDD). We recruited 395 subjects who received monotherapy of mirtazapine or escitalopram and conducted 2-, 4-, 6-, 8-, and 12-week follow-up assessments (<italic>n</italic> = 311, 278, 251, 199, and 178, respectively). Latent profile analysis (LPA) was performed on somatic symptom items of the depression and somatic symptoms scale (DSSS). Generalized linear mixed models (GLMM) were used to study the longitudinal prognosis of the subtypes classed by LPA. Primary outcome measures were the Hamilton Depression Rating Scale (HAMD), HAMD score reduction rate, as well as somatic and depressive items of DSSS.</p></sec><sec><title>Results</title><p>Three subtypes of MDD were found, namely, depression with mild somatic symptoms (68.9%), depression with moderate somatic symptoms (19.2%), and depression with severe somatic symptoms (11.9%). Scores of HAMD (<italic>F</italic> = 3.175, <italic>p</italic> = 0.001), somatic (<italic>F</italic> = 23.594, <italic>p</italic> &lt; 0.001), and depressive (<italic>F</italic> = 4.163, <italic>p</italic> &lt; 0.001) DSSS items throughout the 12-week follow-up showed statistical difference among the three subtypes. The moderate group displayed a higher HAMD-17 score and a lower reduction rate at the 6th week, and more severe depressive symptoms both at the 4th and 6th weeks.</p></sec><sec><title>Conclusion</title><p>The results indicate that somatic symptoms should be emphasized in patients with MDD, and more attention is needed for those with moderate somatic symptoms, which may be relevant to a worse prognosis.</p></sec>